XPR1 Gene Basal Ganglia Calcification Type 6 Idiopathic NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The XPR1 Gene Basal Ganglia Calcification Type 6 Idiopathic NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the XPR1 gene, which plays a crucial role in phosphate transport and cellular metabolism. When this gene malfunctions, it leads to idiopathic basal ganglia calcification type 6—a rare neurological condition characterized by abnormal calcium deposits in the basal ganglia region of the brain.
What This Test Measures and Detects
Our comprehensive NGS-based genetic analysis examines the entire XPR1 gene sequence to identify:
- Pathogenic variants and mutations in the XPR1 gene
- Single nucleotide polymorphisms (SNPs) associated with basal ganglia calcification
- Copy number variations affecting gene function
- Novel mutations that may contribute to disease development
- Inheritance patterns for family risk assessment
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Unexplained movement disorders including tremors, dystonia, or parkinsonism
- Progressive cognitive decline or dementia symptoms
- Psychiatric symptoms such as depression, anxiety, or personality changes
- Family history of basal ganglia calcification or related neurological conditions
- Unexplained seizures or speech difficulties
- Children with developmental delays and neurological symptoms
- Individuals with abnormal brain imaging showing basal ganglia calcification
Key Benefits of Genetic Testing
Undergoing the XPR1 Gene Basal Ganglia Calcification Type 6 test provides numerous advantages:
- Accurate Diagnosis: Confirm or rule out idiopathic basal ganglia calcification type 6
- Early Intervention: Enable timely treatment and management strategies
- Family Planning: Inform reproductive decisions and genetic counseling
- Personalized Care: Guide targeted therapeutic approaches
- Prognostic Information: Understand disease progression and potential outcomes
- Research Contribution: Help advance scientific understanding of rare neurological disorders
Understanding Your Test Results
Our genetic counselors will help you interpret your results with comprehensive guidance:
- Positive Result: Indicates the presence of pathogenic XPR1 gene mutations associated with basal ganglia calcification type 6
- Negative Result: Suggests no detectable mutations in the XPR1 gene, though other genetic or environmental factors may still be involved
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
- Carrier Status: Determines if you carry one copy of a mutated gene that could be passed to offspring
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| XPR1 Gene Basal Ganglia Calcification Type 6 Idiopathic NGS Genetic DNA Test – Discount Price | $500 |
| XPR1 Gene Basal Ganglia Calcification Type 6 Idiopathic NGS Genetic DNA Test – Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible genetic testing services for patients nationwide.
Take Control of Your Neurological Health
Don’t let unexplained neurological symptoms create uncertainty in your life. Our XPR1 Gene Basal Ganglia Calcification Type 6 Idiopathic NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With results available in 3-4 weeks and comprehensive genetic counseling included, you’ll receive the expert guidance necessary to understand your genetic profile and plan your next steps.
Ready to schedule your genetic test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment and take the first step toward understanding your neurological health.
